Delivery Order SPE2DB25D3306-SPE2DB25FUCJM
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a $4,531.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with an ultimate completion date of August 5, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units) with a ceiling value of $2,763.95 and an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order, indicating it falls under a larger indefinite delivery contract vehicle. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5mg (90-count supply) valued at $6,490.08 under a firm fixed price contract type. The award was made on July 24, 2025, with an ultimate completion date of the same day, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,672.24 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,110,874 Letrozole 2.5 mg tablets. The order has an ultimate completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision...
- The Defense Logistics Agency awarded a delivery order valued at $6,117.34 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a quantity of 90s. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. The products will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Letrozole is an aromatase...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,081.68, for the supply of Letrozole 2.5 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 6, 2025. The award was issued on August 5, 2025, with performance to be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Letrozole is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.98 firm fixed-price delivery order is for the supply of 4,567,558,074 units of the drug Letrozole 2.5 mg tablets in 90-count packages. The award has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,489.40 firm fixed-price delivery order is for the supply of 90 tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of July 8, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- The Defense Logistics Agency awarded a $3,725.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Letrozole is an aromatase inhibitor commonly used in hormone therapy for breast cancer treatment, reflecting the Defense Logistics...